China NMPA approves Sanofi’s Qfitlia for haemophilia and Cablivi for acquired thrombotic thrombocytopenic purpura: Paris Friday, December 12, 2025, 09:00 Hrs [IST] The National ...
The FDA has approved Flow Neuroscience's at-home brain stimulation device, FL-100, as a new treatment for depression, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback